Patients with T2D who undergo kidney transplants are less likely to experience organ failure and mortality if they receive ...
HealthDay on MSN2d
GLP-1 Drugs Improve Outlook For Kidney TransplantsGLP-1 drugs like Ozempic can help kidney transplant patients avoid organ failure and live longer, a new study sugges ...
GLP-1 receptor agonists were initially approved for glycaemic control in type 2 diabetes and, subsequently, for bodyweight loss in obesity. Following large-scale trials demonstrating that some GLP-1 ...
News Medical on MSN2d
Study shows benefits of GLP-1 drugs for kidney transplant recipients with type 2 diabetesKidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.
Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to ...
Our study results are the strongest evidence to date that GLP-1 agonist drugs are largely safe and effective tools for addressing type 2 diabetes in kidney transplant recipients." Babak Orandi ...
THURSDAY, March 6, 2025 (HealthDay News) -- GLP-1 drugs like Ozempic can help kidney transplant patients avoid organ failure and live longer, a new study suggests. The drugs help manage patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback